Atrial fibrillation in the intensive care unit

Intensive Care Medicine

Volumn 32, Issue 3, 2006, Pages 345-348

  Heinz, Gottfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; HEPARIN; HYPERTENSIVE AGENT; INOTROPIC AGENT;

AGE DISTRIBUTION; APACHE; CARDIOVASCULAR RISK; CARDIOVERSION; COHORT ANALYSIS; COURSE EVALUATION; CREATININE CLEARANCE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EDITORIAL; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SINUS RHYTHM; SINUS TACHYCARDIA; STROKE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TACHYCARDIA;

AGED; ATRIAL FIBRILLATION; HUMANS; INTENSIVE CARE UNITS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; UNITED STATES;

EID: 33344470467     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-005-0033-1     Document Type: Editorial

References (26)

1. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary a report of the ACC/AHA Task Force on Practice Guidelines and the ESC Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 104:2118-2150
2. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VA, Rautaharju PM (1994) Prevalence of atrial fibrillation in elderly subjects (the cardiovascular health study). Am J Cardiol 74:236-241
3. Kannel WB, Abbott RD, Savage DD, McNamara PM (1983) Coronary heart disease and atrial fibrillation: the Framingham study. Am Heart J 106:389-396
4. Artucio H, Peireira M (1990) Cardiac arrhythmias in critically ill patients: epidemiologic study. Crit Care Med 18:1383-1388
5. Knotzer H, Mayr A, Ulmer H, Lederer W, Schobersberger W, Mutz N, Hasibeder W (2000) Tachyarrhythmias in a surgical intensive care unit: case-controlled epidemiologic study. Intensive Care Med 26:908-914
6. Reinelt P, Delle Karth G, Geppert A, Heinz G (2001) Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiologie ICU. Intensive Care Med 27:1466-1473
7. Seguin P, Signouret T, Laviolle B, Branger B, Malledant Y (2004) Incidence and risk factors of atrial fibrillation in a surgical intensive care unit. Crit Care Med 32:722-726
8. Seguin P, Laviolle B, Maurice A, Lecqulerc C, Malledant Y (2005) Atrial fibrillation in trauma patients requiring intensive care. Intensive Care Med (http://dx.doi.org/10.1007/s00134-005-0032-2)
9. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM (1997) Incidence and risk factors for atrial fibrillation in older adults. Circulation 96:2455-2461
10. Wolf PA, Abbott RD, Kannel WB (1987) Atrial fibrillation: A major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med 7:147:1561-1564
11. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE (1995) The natural history of atrial fibrillation: incidence, risk factors and prognosis in the Mannitoba Follow-up Study. Am J Med 98:476-484
12. Flegel KM, Shipley MJ, Rose G (1987) Risk of stroke in non-rheumatic atrial fibrillation. Lancet I:526-529
13. Epstein AE, Alexander JC, Guttermann DD, Maisel W, Wharton JM (2005) Anticoagulation. ACCP guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128:24S-27S
14. Darius H, Hester K, Sanderink GJ, Paar WD (2004) Antithrombotische Therapie mit niedermolekularen Heparinen bei Niereninsuffizienz. J Kardiol 11:313-316
15. Dorffler-Melly J, de Jonge E, Pont AC, Meijers J, Vroom MB, Buller HR, Levi M (2002) Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet 359:849-850
16. Priglinger U, Delle Karth G, Geppert A, Joukhadar C, Graf S, Berger R, Hülsmann M, Spitzauer S, Pabinger I, Heinz G (2003) Prophylactic anticoagulation with enoxaparin-is the subcutaneous route appropriate in the critically ill? Crit Care Med 31:1405-1409
17. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky LN, Wann LS, Wyse DG (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 22:1852-1923
18. Heinz G (1999) Infektion, Sepsis und kardiale Rhythmusstörungen. Wien Klin Wochenschr 111/21:868-875
19. Koreny M, Reinelt P, Meyer B, Delle Karth G, Geppert A, Hülsmann M, Priglinger U, Berger R, Heinz G (2005) Dynamics of inflammation parameters prior to tachyarrhythmias in critically ill patients. Wien Klin Wochenschr 117:342-347
20. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, van Wagoner DR (2001) C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104:2886-2891
21. Steinacher R (2004) Inflammatory response in a mixed cardiological- postsurgical intensiv care unit. Thesis, Vienna Medical School
22. Brathwaite D, Weissmann C (1998) The new onset of atrial arrhythmias following major noncardiothoracic surgery is associated with increased mortality. Chest 114:462-468
23. Mayr A, Ritsch N, Knotzer H, Dunser M, Schobersberger W, Ulmer H, Mutz N, Hasibeder W (2003) Effectiveness of direct-current cardioversion for treatment of supraventricular tachyarrhythmias, in particular atrial fibrillation, in surgical intensive care patients. Crit Care Med 31:401-405
24. Hausleitner I, Domanovits H, Schillinger M, Gamper G, Laggner A (2002) External electrical cardioversion of persistent atrial fibrillation (abstract). Resuscitation 55:76
25. Martinez EA, Epstein A, Bass EB (2005) Pharmacologic control of ventricular rate. ACCP guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128:56S-60S
26. Delle Karth G, Geppert A, Neunteufl T, Priglinger U, Haumer M, Gschwandtner M, Siostrzonek P, Heinz G (2001) Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 29:1149-1153